Lenostella

Levonorgestrel, the active ingredient in Lenostella, is a progestogen presented as a tablet for oral use. It is employed to prevent pregnancy after unprotected sexual intercourse and as a component of hormonal contraceptive regimens in women of reproductive age.

GNH USA supplies Lenostella as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution.

Lenostella (levonorgestrel) is used within the progestogen pathway for hormonal contraception.

- Emergency contraception: prevents pregnancy when taken within 72‑120 hours after unprotected intercourse. - Regular contraception: provides ongoing prevention of ovulation when incorporated into approved hormonal regimens. - Menstrual cycle management: may be used to delay or regulate the onset of menstruation under medical supervision.

Levonorgestrel may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects: - Nausea: mild stomach upset. - Headache: transient cranial pain. - Fatigue: feeling of tiredness. - Menstrual changes: spotting or altered bleeding pattern.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, difficulty breathing. - Thromboembolic events: blood clot formation. - Liver dysfunction: jaundice or elevated liver enzymes.

When considering Lenostella, several precautionary measures should be observed to ensure safe use.

- Timing of administration: take as soon as possible after unprotected intercourse for maximum efficacy. - Contraindications: avoid if known hypersensitivity to levonorgestrel or other progestogens. - Existing pregnancy: do not use if confirmed pregnancy; it does not terminate an existing pregnancy. - Drug interactions: review concomitant medications that may reduce effectiveness, such as enzyme inducers. - Medical conditions: consult a healthcare professional if you have liver disease, uncontrolled epilepsy, or hormonal disorders. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Levonorgestrel can interact with other medicines, affecting its efficacy or safety profile.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampicin, carbamazepine, phenytoin): may markedly reduce contraceptive effectiveness. - Antifungal agents (e.g., griseofulvin): can lower plasma levels of levonorgestrel. - St. John’s wort: herbal inducer that may compromise emergency contraception.

Moderate Interactions (Monitor Closely): - Antiretrovirals (e.g., efavirenz): may modestly decrease efficacy; monitor for breakthrough. - Hormonal therapies (e.g., estrogen‑containing contraceptives): assess combined hormonal effects. - Anticonvulsants (e.g., phenobarbital): may require alternative contraceptive measures.